Open AccessAdalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: An open-label study
Author(s) -
Laurent PeyrinBiroulet
Publication year - 2007
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v13.i16.2328
Subject(s) - adalimumab , medicine , ulcerative colitis , infliximab , gastroenterology , colectomy , placebo , colitis , surgery , rheumatoid arthritis , tumor necrosis factor alpha , pathology , alternative medicine , disease
To evaluate the efficacy of adalimumab induction therapy in patients with ulcerative colitis who previously responded to infliximab and then lost response or became intolerant.